Table 1 Participant characteristics.

From: Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

 

Oxytocin

Placebo

Number of participants

21

17

Age

24.76 ± 4.85

24.06 ± 5.54

Handedness

5L/16R

2L/15R

IQ

Total IQ

102 ± 13

107 ± 19

VIQ

106 ± 9

111 ± 13

PIQ

105 ± 18

104 ± 22

ADOS-2

Total

7.2 ± 4.3

7.6 ± 3.9

Communication

2.1 ± 1.4

2.2 ± 1.4

Social interaction

5.1 ± 3.4

5.4 ± 3.1

Use of psychostimulant medication

5

2

Comorbidity

7

2

  1. Data are shown as mean ± standard deviation. Detailed information on medication use and comorbidities is provided in Supplementary Table 1.
  2. L left-handed, R right-handed, IQ intelligence quotient, VIQ verbal IQ, PIQ performance IQ, ADOS autism diagnostic observation schedule.
Back to article page